(Press-News.org) Gene therapy researchers have produced a bioengineered decoy that fools the immune system and prevents it from mistakenly defeating the benefits delivered by a corrective gene. The decoy was effective in animal studies, and if the approach succeeds in humans, it offers a potential new treatment for genetic diseases such as hemophilia, while advancing the broader field of gene therapy.
"This decoy strategy could be individualized to patients and could greatly expand the population of patients who may benefit from gene therapy," said study leader Katherine A. High, M.D., director of the Center for Cellular and Molecular Therapeutics (CCMT) at The Children's Hospital of Philadelphia. "Right now, 30 to 60 percent of adult patients develop antibodies that block the ability of an intravenously infused vector to reach the target cells in the liver. This approach holds the promise of overcoming this roadblock—pre-existing antibodies—and allowing successful intravenous gene therapy in virtually all adult patients."
High and co-corresponding author Federico Mingozzi, Ph.D., formerly of Children's Hospital, published the team's study today in Science Translational Medicine.
High, a Howard Hughes Medical Institute Investigator, has led pioneering investigations of gene therapy at Children's Hospital for the inherited bleeding disorder hemophilia and other diseases.
Previously, in clinical trials, High used adeno-associated virus (AAV) as a vector—a delivery vehicle—to ferry a corrective DNA sequence to patients with a mutation causing hemophilia B, the second most common form of the disease. The delivered gene enables the patient to produce a needed blood-clotting factor.
AAV does not cause human disease, but because we are routinely exposed to this virus, 30 to 60 percent of people develop antibodies that neutralize AAV if it enters the circulation. To extend the potential benefits of gene therapy to a broader population, researchers have long sought ways to better manage this immune response. The decoy strategy could solve this challenge for any disease in which vectors must be delivered through the circulation.
The current study by High and colleagues relies on a capsid, the protein shell surrounding a virus. Following in vitro studies in human serum, the researchers injected empty AAV capsids along with gene therapy vectors into a mouse model. The anti-AAV neutralizing antibodies bound to the capsid decoys, allowing the DNA-carrying vectors to evade the antibodies and enter the targeted cells in the liver.
The study team next engineered the capsids to disable their ability to enter target cells. This prevented the capsids from triggering a second immune response, from T cells, that also could eliminate the corrective genes. The gene therapy was safe and effective in rhesus macaque monkeys, which produced higher levels of clotting factor, with no adverse effects.
"Our results, which held up over a range of doses, suggest that in clinical studies, it will be feasible to adjust the ratio of empty capsids to gene vector doses, depending on an individual's pre-existing level of neutralizing antibodies," said High. "That means we could personalize gene therapy to make it more efficient for each patient."
"This work should make it possible to bring effective gene therapy to most adults with severe hemophilia B," High continued. "Each patient would receive a personalized final formulation that contains just the right amount of empty capsid to neutralize any pre-existing antibody, and allow the gene-expressing vector to reach the liver."
INFORMATION:
Support for this study came from the National Institutes of Health (grant HL078810) and the Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia. The Howard Hughes Medical Institute (HHMI) also provided support.
High's and Mingozzi's co-authors were from Children's Hospital and the Perelman School of Medicine at the University of Pennsylvania (where High is a faculty member). Another co-author was Xavier M. Anguela, Ph.D., of both the CCMT and HHMI.
"Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys," Science Translational Medicine, published online July 17, 2013.
About The Children's Hospital of Philadelphia: The Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program receives the highest amount of National Institutes of Health funding among all U.S. children's hospitals. In addition, its unique family-centered care and public service programs have brought the 516-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu.
Empty decoys divert antibodies from neutralizing gene therapy in cell, animal studies
CHOP-led research dramatically increases numbers of patients who could be treated with gene therapy
2013-07-18
ELSE PRESS RELEASES FROM THIS DATE:
Scripps Research Institute scientists find 3D structure of key drug target for diabetes
2013-07-18
LA JOLLA, CA -- An international team led by scientists at The Scripps Research Institute (TSRI) has determined and analyzed the three-dimensional atomic structure of the human glucagon receptor. The receptor, found mainly on liver and kidney cells, helps regulate glucose levels in the bloodstream and is the target of potential therapeutic agents for type 2 diabetes.
"Our data should change the current view of how drugs are designed with this and related receptors," said TSRI Research Associate Fai Yiu Siu, PhD, who was first author of the study.
The study is reported ...
Mutation linked to congenital urinary tract defects
2013-07-18
NEW YORK, NY (July 17, 2013) — Researchers at Columbia University Medical Center (CUMC) and collaborators have identified a genetic mutation that causes congenital malformations of the kidney and urinary tract, a common form of birth defect and the most common cause of kidney failure in children. It is the first time that a specific genetic mutation has been linked to a non-syndromic form of urinary tract malformation. The findings were published in the July 17 online issue of the New England Journal of Medicine.
The research team, led by Ali Gharavi, MD, associate professor ...
Impossible material made by Uppsala University researchers
2013-07-18
A novel material with world record breaking surface area and water adsorption abilities has been synthesized by researchers from Uppsala University, Sweden. The results are published today in PLOS ONE.
The magnesium carbonate material that has been given the name Upsalite is foreseen to reduce the amount of energy needed to control environmental moisture in the electronics and drug formulation industry as well as in hockey rinks and ware houses. It can also be used for collection of toxic waste, chemicals or oil spill and in drug delivery systems, for odor control and ...
'Intelligent knife' tells surgeon which tissue is cancerous
2013-07-18
Scientists have developed an "intelligent knife" that can tell surgeons immediately whether the tissue they are cutting is cancerous or not.
In the first study to test the invention in the operating theatre, the "iKnife" diagnosed tissue samples from 91 patients with 100 per cent accuracy, instantly providing information that normally takes up to half an hour to reveal using laboratory tests.
The findings, by researchers at Imperial College London, are published today in the journal Science Translational Medicine. The study was funded by the National Institute for Health ...
Earth's gold came from colliding dead stars
2013-07-18
We value gold for many reasons: its beauty, its usefulness as jewelry, and its rarity. Gold is rare on Earth in part because it's also rare in the universe. Unlike elements like carbon or iron, it cannot be created within a star. Instead, it must be born in a more cataclysmic event - like one that occurred last month known as a short gamma-ray burst (GRB).
Observations of this GRB provide evidence that it resulted from the collision of two neutron stars - the dead cores of stars that previously exploded as supernovae. Moreover, a unique glow that persisted for days at ...
Conflict threatens global nutrition progress, new report warns
2013-07-18
Major progress in tackling child undernutrition in some of the world's toughest countries is under threat as military and security funding takes precedence, a new report from aid agency World Vision warns.
The number of children under five who die every year has decreased by half since 1990. Yet, World Vision's Fragile but not Helpless report (PDF) finds that this progress is under threat. Countries marred by conflict or fragility have some of the highest rates of acute and chronic undernutrition in the world.
In Africa alone it is on average 50 percent higher in fragile ...
Researchers reveal great white sharks' fuel for oceanic voyages: Liver oil
2013-07-18
Great white sharks are not exactly known as picky eaters, so it might seem obvious that these voracious predators would dine often and well on their migrations across the Pacific Ocean. But not so, according to new research by scientists at Stanford University and the Monterey Bay Aquarium.
The researchers' findings, published July 17 in Proceedings of the Royal Society B, reveal previously unknown details of how great white sharks power themselves and stay buoyant on non-stop trips of more than 2,500 miles. The discoveries have potentially broad implications for conservation ...
Nano drug crosses blood-brain tumor barrier, targets brain-tumor cells and blood vessels
2013-07-18
The blood-brain barrier protects the brain from poisons but also prevents drugs from reaching brain tumors; innovative new treatments are needed.
This laboratory study shows that a nanotechnology drug called SapC-DOPS crosses that barrier and targets brain-tumor cells and retards growth of tumor blood vessels.
The findings also show how the agent targets tumor cells and recommend its further development as a novel treatment for glioblastoma.
COLUMBUS, Ohio – An experimental drug in early development for aggressive brain tumors can cross the blood-brain tumor barrier ...
The best defense against catastrophic storms: Mother Nature, say Stanford researchers
2013-07-18
Extreme weather, sea level rise and degraded coastal systems are placing people and property at greater risk along the coast. Natural habitats such as dunes and reefs are critical to protecting millions of U.S. residents and billions of dollars in property from coastal storms, according to a new study by scientists with the Natural Capital Project at the Stanford Woods Institute for the Environment.
The study, "Coastal habitats shield people and property from sea-level rise and storms," published July 14 in the journal Nature Climate Change, offers the first comprehensive ...
Splitting donated livers shown to be safe, allowing doctors to save 2 lives from single organ
2013-07-18
Boston, Mass—Split liver transplantation carries no increased risk of failure in either recipient, allowing surgeons to safely save two lives from a single donated organ (graft), according to new research from Boston Children's Hospital published online in the Journal of the American College of Surgeons.
Due to their regenerative nature, livers donated by a deceased adult or adolescent can be surgically split into two unequally sized portions; the smaller segment is allocated to a young child awaiting transplant and the larger portion to an adult.
"Infants waiting ...
LAST 30 PRESS RELEASES:
Cambridge study shows stem cell grafts can restore myelin in MS lesions in mice
Mediterranean bacteria may harbor new mosquito solution
New study maps four key pathways to Alzheimer’s disease
Voracious honey bees threaten the food supply of native pollinators
Despite dwindling resources, report of successful arts education models worldwide paints bright picture
How does body mass index affect breast cancer risk in postmenopausal women with and without cardiovascular disease?
Where the feral buffalo roam in Hong Kong
Dark Dwarfs lurking at the center of our Galaxy might hint at the nature of dark matter
From position to meaning: how AI learns to read
AI revives classic microscopy for on-farm soil health testing
Fig trees convert atmospheric CO2 to stone
Intra-arterial tenecteplase for acute stroke after successful endovascular therapy
Study reveals beneficial microbes that can sustain yields in unfertilized fields
Robotic probe quickly measures key properties of new materials
Climate change cuts milk production, even when farmers cool their cows
Frozen, but not sealed: Arctic Ocean remained open to life during ice ages
Some like it cold: Cryorhodopsins
Demystifying gut bacteria with AI
Human wellbeing on a finite planet towards 2100: new study shows humanity at a crossroads
Unlocking the hidden biodiversity of Europe’s villages
Planned hydrogen refuelling stations may lead to millions of euros in yearly losses
Planned C-sections increase the risk of certain childhood cancers
Adults who have survived childhood cancer are at increased risk of severe COVID-19
Drones reveal extreme coral mortality after bleaching
New genetic finding uncovers hidden cause of arsenic resistance in acute promyelocytic leukemia
Native habitats hold the key to the much-loved smashed avocado’s future
Using lightning to make ammonia out of thin air
Machine learning potential-driven insights into pH-dependent CO₂ reduction
Physician associates provide safe care for diagnosed patients when directly supervised by a doctor
How game-play with robots can bring out their human side
[Press-News.org] Empty decoys divert antibodies from neutralizing gene therapy in cell, animal studiesCHOP-led research dramatically increases numbers of patients who could be treated with gene therapy